October 23, 2026
Zoetis shares fell only 1.2 percent after cutting its outlook, a surprisingly mild reaction for a company whose move was bigger than 61 percent of its trading days over three years.
What happened
Zoetis missed earnings or cut guidance and its stock fell 1.2 percent. Abbott Laboratories also reported an earnings miss, and its shares declined. The two moves together swung roughly 100 billion dollars of market value.
Why it matters
Guidance cuts and earnings misses normally rattle animal health and medical device peers, but the calm market stress reading suggests broad fear did not spread. Falling government bond yields, up 0.7 percent over the past week, and still-constructive market trends may have cushioned the names, absorbing the negative news without a wider selloff.
The case against
A single session drop of 1.2 percent might be the start of more pain. If chip stocks keep pulling back and defence stocks, already lagging the market by 2.8 percent over the past week, worsen, sentiment could sour and turn these modest declines into deeper ones.
What settles it
Whether the market trend flips from constructive to negative in the next few sessions, which would signal if investors are truly shrugging off or merely delaying a repricing of earnings misses.